Emerald Mutual Fund Advisers Trust Ptc Therapeutics, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$42.56 - $54.98 $3.65 Million - $4.71 Million	-85,696 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$32.37 - $59.36 $9.36 Million - $17.2 Million	-289,150 Reduced 77.14%	85,696 $3.82 Million
Q4 2019 Jan 29, 2020	BUY	$32.22 - $50.07 $368,403 - $572,500	11,434 Added 3.15%	374,846 $18 Million
Q3 2019 Oct 31, 2019	BUY	$33.82 - $48.17 $293,016 - $417,344	8,664 Added 2.44%	363,412 $12.3 Million
Q2 2019 Jul 31, 2019	BUY	$35.42 - $45.0 $2.83 Million - $3.6 Million	80,036 Added 29.13%	354,748 $16 Million
Q1 2019 May 01, 2019	BUY	$28.09 - $39.49 $1.89 Million - $2.66 Million	67,359 Added 32.49%	274,712 $10.3 Million
Q3 2018 Oct 31, 2018	BUY	$33.9 - $47.77 $7.03 Million - $9.91 Million	207,353 New	207,353 $9.75 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.